MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Gross Profit Margin (Quarterly): 61.22% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.22% |
| June 30, 2024 | 59.96% |
| March 31, 2024 | 60.82% |
| December 31, 2023 | 65.32% |
| September 30, 2023 | 64.87% |
| June 30, 2023 | 59.66% |
| March 31, 2023 | 59.29% |
| Date | Value |
|---|---|
| December 31, 2022 | 56.04% |
| September 30, 2022 | 55.79% |
| June 30, 2022 | 42.43% |
| March 31, 2022 | 46.56% |
| December 31, 2021 | 46.35% |
| September 30, 2021 | 46.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
42.43%
Minimum
Jun 2022
65.32%
Maximum
Dec 2023
55.76%
Average
59.29%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Galapagos NV | 99.97% |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 61.93% |
| Celyad Oncology SA | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -650.1% |
| Return on Assets | -31.08% |
| Return on Invested Capital | -85.88% |
| Profit Margin (Quarterly) | -47.99% |
| Operating Margin (Quarterly) | -26.13% |
| Return on Net Operating Assets | -40.03% |